HIV/AIDS Clinical Trial
Official title:
Assessing the Impact of an Educational HIV Prevention Intervention in Zambia
Verified date | January 2019 |
Source | Columbia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In Zambia, 13% of the 15 to 49 year old population lives with HIV. The highest number of new
HIV infections is among young people. To counter the spread of the disease, developmental and
governmental actors are increasingly relying on educational behavior change tools. A
particularly widely used tool, implemented by the German Development Corporation (henceforth,
GIZ), is the so-called "Join-In-Circuit on AIDS, Love Sexuality" (JIC). The tool aims to
improve a) HIV and sexual reproductive health knowledge, b) HIV testing uptake, and c) demand
for health services. Previous research has investigated the direct effect of the JIC on
knowledge about Sexually Transmitted Infections (STIs) as well as self-reported sexual
behavior in Zimbabwe, and has found positive effects in both domains.
The research project evaluates the JIC in Zambia. The study randomly assigns 170
participating schools to five different JIC treatment arms. The first two arms represent
control schools. Here, no JIC will be implemented. The third arm implements the JIC among a
random subset of students. The fourth arm implements the JIC among indegree central students.
The fifth arm implements the JIC among edge betweeness central students. In each school, the
JIC will be implemented in one pre-determined grade. Within each school at least 30 students
will be selected. For larger schools, 20 percent of students in the selected grade are
selected.
Status | Completed |
Enrollment | 8270 |
Est. completion date | December 2, 2017 |
Est. primary completion date | December 2, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 14 Years to 22 Years |
Eligibility |
Inclusion Criteria: - Students must be enrolled in the selected grade in one of the study schools and present on the day of the interview (for piloting) or on the day of baseline and endline (for main evaluation) - Students must have informed consent - Students must speak English or Tonga Exclusion Criteria: - There are no exclusion criteria within the pre-defined schools |
Country | Name | City | State |
---|---|---|---|
United States | Columbia University | New York | New York |
Zambia | American Institutes for Research | Choma | |
Zambia | American Institutes for Research | Livingstone |
Lead Sponsor | Collaborator |
---|---|
Columbia University | American Institutes for Research, German Development Corporation |
United States, Zambia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Standardized index of knowledge about sexual and reproductive health | The investigators created an overall index that standardizes the outcome variables, which is split into a knowledge index and a self-reported behavior. This index will be constructed from a battery of survey items pertaining to knowledge about condoms, HIV/Aids and other STIs. | Up to 6 months after the study implementation | |
Secondary | Standardized index of self-reported behavior | The investigators created an overall index that standardizes the outcome variables, which is split into a knowledge index and a self-reported behavior. This index will be constructed form a battery of survey items measuring self-reported behavior pertaining to sex, HIV testing, and access of health facilities. | Up to 6 months after the study implementation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|